{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:11:03Z","timestamp":1784700663815,"version":"3.55.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semdiagpath.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1053\/j.semdp.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T18:09:01Z","timestamp":1463422141000},"page":"294-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Multicentric Castleman disease: Where are we now?"],"prefix":"10.1053","volume":"33","author":[{"given":"Hao-Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJM195401072500107","article-title":"CASE records of the Massachusetts General Hospital weekly clinicopathological exercises: case 40011","volume":"250","author":"Castleman","year":"1954","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymphnode hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","article-title":"Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations","volume":"29","author":"Keller","year":"1972","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00000478-198304000-00001","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman\u05f3s disease. Pathological findings in 15 patients","volume":"7","author":"Frizzera","year":"1983","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2016.05.006_bib6","first-page":"626","article-title":"Systemic lymphoproliferative disorder with morphologic features of Castleman\u05f3s disease. Immunoperoxidase study of cytoplasmic immunoglobulins","volume":"108","author":"Miller","year":"1984","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1053\/j.semdp.2016.05.006_bib7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman\u05f3s disease: clinical findings and clinicopathologic correlations in 15 patients","volume":"3","author":"Frizzera","year":"1985","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.semdp.2016.05.006_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM198402163100713","article-title":"Hypervascular follicular hyperplasia and Kaposi\u05f3s sarcoma in patients at risk for AIDS","volume":"310","author":"Harris","year":"1984","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/83.1.27","article-title":"Multicentric angiofollicular lymph node hyperplasia (Castleman\u05f3s disease) followed by Kaposi\u05f3s sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS)","volume":"83","author":"Lachant","year":"1985","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2016.05.006_bib10","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/1097-0142(19871115)60:10<2454::AID-CNCR2820601018>3.0.CO;2-I","article-title":"Generalized lymphadenopathy with morphologic features of Castleman\u05f3s disease in an HIV-positive man","volume":"60","author":"Lowenthal","year":"1987","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","article-title":"Multicentric Castleman\u05f3s disease in HIV infection: a clinical and pathological study of 20 patients","volume":"10","author":"Oksenhendler","year":"1996","journal-title":"AIDS"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib12","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u05f3s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.semdp.2016.05.006_bib13","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib14","first-page":"346","article-title":"Castleman\u05f3s disease and related disorders","volume":"5","author":"Frizzera","year":"1988","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/SLA.0b013e318249dcdc","article-title":"Surgery in Castleman\u05f3s disease: a systematic review of 404 published cases","volume":"255","author":"Talat","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<294::AID-CNCR13>3.0.CO;2-W","article-title":"Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized","volume":"79","author":"Chan","year":"1997","journal-title":"Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1365-2559.2001.01134.x","article-title":"Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman\u05f3s disease of the nasopharynx: tracing its evolution by sequential biopsies","volume":"38","author":"Chan","year":"2001","journal-title":"Histopathology"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00000478-200006000-00016","article-title":"A chromosomal abnormality in hyaline vascular Castleman\u05f3s disease: evidence for clonal proliferation of dysplastic stromal cells","volume":"24","author":"Pauwels","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.05.006_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000478-200205000-00013","article-title":"Hyaline vascular Castleman\u05f3s disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis","volume":"26","author":"Cokelaere","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/modpathol.2013.202","article-title":"Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease","volume":"27","author":"Chang","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2559.1989.tb02110.x","article-title":"Monoclonality and polyclonality of plasma cells in Castleman\u05f3s disease of the plasma cell variant","volume":"14","author":"Radaszkiewicz","year":"1989","journal-title":"Histopathology"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2559.1989.tb02162.x","article-title":"An immunohistological and genotypic study of the plasma cell form of Castleman\u05f3s disease","volume":"14","author":"Hall","year":"1989","journal-title":"Histopathology"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1309\/AJCPV1I2QWKZKNJH","article-title":"Plasmablastic lymphoma and related disorders","volume":"136","author":"Hsi","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.05.006_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCO.0b013e328355e0f3","article-title":"Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"24","author":"Uldrick","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2016.05.006_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2559.2008.03144.x","article-title":"Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD)","volume":"53","author":"Chadburn","year":"2008","journal-title":"Histopathology"},{"issue":"7","key":"10.1053\/j.semdp.2016.05.006_bib26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.V97.7.2130","article-title":"Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders","volume":"97","author":"Du","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2016.05.006_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.3880635","article-title":"Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8","volume":"15","author":"Wakely","year":"2002","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI44185","article-title":"KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation","volume":"121","author":"Hassman","year":"2011","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ni.1732","article-title":"Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals","volume":"10","author":"Derudder","year":"2009","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI44417","article-title":"Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice","volume":"121","author":"Ballon","year":"2011","journal-title":"J Clin Investig"},{"issue":"5192","key":"10.1053\/j.semdp.2016.05.006_bib31","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u05f3s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.seminoncol.2014.12.027","article-title":"Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment","volume":"42","author":"Bhutani","year":"2015","journal-title":"Semin Oncol"},{"issue":"18","key":"10.1053\/j.semdp.2016.05.006_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.semdp.2016.05.006_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi\u05f3s sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib35","doi-asserted-by":"crossref","first-page":"e1000935","DOI":"10.1371\/journal.ppat.1000935","article-title":"The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes","volume":"6","author":"Gunther","year":"2010","journal-title":"PLoS Pathog"},{"issue":"18","key":"10.1053\/j.semdp.2016.05.006_bib36","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.95.18.10866","article-title":"A viral gene that activates lytic cycle expression of Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"95","author":"Sun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1053\/j.semdp.2016.05.006_bib37","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.1128\/JVI.79.22.14371-14382.2005","article-title":"Role of Notch signal transduction in Kaposi\u05f3s sarcoma-associated herpesvirus gene expression","volume":"79","author":"Chang","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/JVI.01192-15","article-title":"Induction of Kaposi sarcoma herpesvirus-encoded viral interleukin-6 by X-box binding protein-1","volume":"90","author":"Hu","year":"2015","journal-title":"J Virol"},{"issue":"5","key":"10.1053\/j.semdp.2016.05.006_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nri2076","article-title":"Immune evasion by Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"7","author":"Coscoy","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"5293","key":"10.1053\/j.semdp.2016.05.006_bib40","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","article-title":"Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV","volume":"274","author":"Moore","year":"1996","journal-title":"Science"},{"key":"10.1053\/j.semdp.2016.05.006_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coviro.2015.08.016","article-title":"Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis","volume":"14","author":"Schulz","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1053\/j.semdp.2016.05.006_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","article-title":"Gammaherpesviruses and lymphoproliferative disorders","volume":"9","author":"Cesarman","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2016.05.006_bib43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0198-8859(99)00083-X","article-title":"KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways","volume":"60","author":"Osborne","year":"1999","journal-title":"Hum Immunol"},{"issue":"11","key":"10.1053\/j.semdp.2016.05.006_bib44","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/JVI.74.11.5300-5309.2000","article-title":"Downregulation of major histocompatibility complex class I molecules by Kaposi\u05f3s sarcoma-associated herpesvirus K3 and K5 proteins","volume":"74","author":"Ishido","year":"2000","journal-title":"J Virol"},{"issue":"14","key":"10.1053\/j.semdp.2016.05.006_bib45","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1073\/pnas.140129797","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis","volume":"97","author":"Coscoy","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1053\/j.semdp.2016.05.006_bib46","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L","article-title":"Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II","volume":"31","author":"Weber","year":"2001","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V95.4.1151.004k37_1151_1157","article-title":"KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells","volume":"95","author":"Stine","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semdp.2016.05.006_bib48","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1084\/jem.189.12.1993","article-title":"The Kaposi\u05f3s sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8","volume":"189","author":"Endres","year":"1999","journal-title":"J Exp Med"},{"issue":"11","key":"10.1053\/j.semdp.2016.05.006_bib49","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/emboj\/21.11.2602","article-title":"Characterization of an anti-apoptotic glycoprotein encoded by Kaposi\u05f3s sarcoma-associated herpesvirus which resembles a spliced variant of human survivin","volume":"21","author":"Wang","year":"2002","journal-title":"EMBO J"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1073\/pnas.94.2.690","article-title":"A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak","volume":"94","author":"Cheng","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1053\/j.semdp.2016.05.006_bib51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.onc.1204163","article-title":"HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP\/p300 coactivators","volume":"20","author":"Lin","year":"2001","journal-title":"Oncogene"},{"issue":"13","key":"10.1053\/j.semdp.2016.05.006_bib52","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1128\/JVI.75.13.6193-6198.2001","article-title":"Viral interferon regulatory factor 1 of Kaposi\u05f3s sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis","volume":"75","author":"Seo","year":"2001","journal-title":"J Virol"},{"issue":"8","key":"10.1053\/j.semdp.2016.05.006_bib53","doi-asserted-by":"crossref","first-page":"e1001031","DOI":"10.1371\/journal.ppat.1001031","article-title":"Bim nuclear translocation and inactivation by viral interferon regulatory factor","volume":"6","author":"Choi","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib54","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/JVI.80.6.3092-3097.2006","article-title":"Inhibition of interferon signaling by the Kaposi\u05f3s sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein","volume":"80","author":"Fuld","year":"2006","journal-title":"J Virol"},{"issue":"15","key":"10.1053\/j.semdp.2016.05.006_bib55","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.00235-07","article-title":"Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi\u05f3s sarcoma-associated herpesvirus viral IRF homolog vIRF3","volume":"81","author":"Joo","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib56","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/0008-5472.CAN-07-2766","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression","volume":"68","author":"Shin","year":"2008","journal-title":"Cancer Res"},{"issue":"13","key":"10.1053\/j.semdp.2016.05.006_bib57","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1074\/jbc.M809252200","article-title":"The Kaposi\u05f3s Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5","volume":"284","author":"Wies","year":"2009","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1053\/j.semdp.2016.05.006_bib58","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1128\/JVI.02353-08","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway","volume":"83","author":"Lee","year":"2009","journal-title":"J Virol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib59","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/JVI.00694-11","article-title":"Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi\u05f3s sarcoma-associated herpesvirus lytic promoters","volume":"86","author":"Xi","year":"2012","journal-title":"J Virol"},{"issue":"6624","key":"10.1053\/j.semdp.2016.05.006_bib60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/386517a0","article-title":"Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors","volume":"386","author":"Thome","year":"1997","journal-title":"Nature"},{"issue":"16","key":"10.1053\/j.semdp.2016.05.006_bib61","doi-asserted-by":"crossref","first-page":"13745","DOI":"10.1074\/jbc.M110480200","article-title":"The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex","volume":"277","author":"Liu","year":"2002","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1053\/j.semdp.2016.05.006_bib62","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/sj.onc.1206407","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK\/AP1 pathways","volume":"22","author":"An","year":"2003","journal-title":"Oncogene"},{"issue":"11","key":"10.1053\/j.semdp.2016.05.006_bib63","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ncb1980","article-title":"FLIP-mediated autophagy regulation in cell death control","volume":"11","author":"Lee","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib64","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1128\/JVI.71.6.4193-4198.1997","article-title":"The cyclin encoded by Kaposi\u05f3s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1","volume":"71","author":"Godden-Kent","year":"1997","journal-title":"J Virol"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/emboj\/18.3.644","article-title":"Degradation of p27(Kip) cdk inhibitor triggered by Kaposi\u05f3s sarcoma virus cyclin-cdk6 complex","volume":"18","author":"Ellis","year":"1999","journal-title":"EMBO J"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib66","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/emboj\/18.3.654","article-title":"Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"18","author":"Mann","year":"1999","journal-title":"EMBO J"},{"issue":"10","key":"10.1053\/j.semdp.2016.05.006_bib67","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/JVI.76.10.4688-4698.2002","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production","volume":"76","author":"Chung","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib68","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcp.21722","article-title":"vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity","volume":"219","author":"Salata","year":"2009","journal-title":"J Cell Physiol"},{"issue":"17","key":"10.1053\/j.semdp.2016.05.006_bib69","first-page":"4873","article-title":"The Kaposi\u05f3s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha","volume":"60","author":"Sodhi","year":"2000","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib70","first-page":"2641","article-title":"The Kaposi\u05f3s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt\/protein kinase B","volume":"61","author":"Montaner","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1535-6108(03)00024-2","article-title":"Kaposi\u05f3s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2\/ KDR","volume":"3","author":"Bais","year":"2003","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1053\/j.semdp.2016.05.006_bib72","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2003-12-4436","article-title":"The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia","volume":"104","author":"Montaner","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","article-title":"The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi\u05f3s sarcoma-associated herpesvirus G protein-coupled receptor","volume":"10","author":"Sodhi","year":"2006","journal-title":"Cancer Cell"},{"issue":"32","key":"10.1053\/j.semdp.2016.05.006_bib74","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1073\/pnas.1001065107","article-title":"Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi\u05f3s sarcoma","volume":"107","author":"Ma","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6764","key":"10.1053\/j.semdp.2016.05.006_bib75","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"issue":"5414","key":"10.1053\/j.semdp.2016.05.006_bib76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.284.5414.641","article-title":"Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen","volume":"284","author":"Ballestas","year":"1999","journal-title":"Science"},{"issue":"10","key":"10.1053\/j.semdp.2016.05.006_bib77","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/80459","article-title":"The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells","volume":"6","author":"Radkov","year":"2000","journal-title":"Nat Med"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V99.2.649","article-title":"The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element","volume":"99","author":"An","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semdp.2016.05.006_bib79","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1128\/JVI.78.12.6585-6594.2004","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency","volume":"78","author":"Lan","year":"2004","journal-title":"J Virol"},{"issue":"5710","key":"10.1053\/j.semdp.2016.05.006_bib80","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.1105779","article-title":"The kaposin B protein of KSHV activates the p38\/MK2 pathway and stabilizes cytokine mRNAs","volume":"307","author":"McCormick","year":"2005","journal-title":"Science"},{"issue":"15","key":"10.1053\/j.semdp.2016.05.006_bib81","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1128\/JVI.02976-12","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus kaposin B induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28","volume":"87","author":"King","year":"2013","journal-title":"J Virol"},{"issue":"5","key":"10.1053\/j.semdp.2016.05.006_bib82","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/JVI.73.5.4181-4187.1999","article-title":"Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi\u05f3s sarcoma, primary effusion lymphoma, and multicentric Castleman\u05f3s disease","volume":"73","author":"Staskus","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/viro.2000.0196","article-title":"Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi\u05f3s sarcoma, and multicentric Castleman\u05f3s disease","volume":"269","author":"Katano","year":"2000","journal-title":"Virology"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib84","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0002-9440(10)64940-1","article-title":"Differential viral protein expression in Kaposi\u05f3s sarcoma-associated herpesvirus-infected diseases: Kaposi\u05f3s sarcoma, primary effusion lymphoma, and multicentric Castleman\u05f3s disease","volume":"156","author":"Parravicini","year":"2000","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2016.05.006_bib85","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1086\/652869","article-title":"Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma","volume":"201","author":"Burbelo","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2016.05.006_bib86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2012.00073","article-title":"Clinical manifestations of kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome","volume":"3","author":"Polizzotto","year":"2012","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib87","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069","article-title":"High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients","volume":"96","author":"Oksenhendler","year":"2000","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.semdp.2016.05.006_bib88","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2008-12-197053","article-title":"Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease","volume":"113","author":"Bower","year":"2009","journal-title":"Blood"},{"issue":"26","key":"10.1053\/j.semdp.2016.05.006_bib89","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","article-title":"Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"122","author":"Polizzotto","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib90","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/JVI.71.1.839-842.1997","article-title":"Human herpesvirus 8 encodes a homolog of interleukin-6","volume":"71","author":"Neipel","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib91","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jmb.2003.10.070","article-title":"Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6","volume":"335","author":"Boulanger","year":"2004","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/152581600319351","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-encoded interleukin-6","volume":"9","author":"Aoki","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"issue":"8","key":"10.1053\/j.semdp.2016.05.006_bib93","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1182\/blood.V97.8.2526","article-title":"Serum viral interleukin-6 in AIDS-related multicentric Castleman disease","volume":"97","author":"Aoki","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semdp.2016.05.006_bib94","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034","article-title":"Angiogenesis and hematopoiesis induced by Kaposi\u05f3s sarcoma-associated herpesvirus-encoded interleukin-6","volume":"93","author":"Aoki","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib95","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/cyto.2002.2012","article-title":"Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman\u05f3s disease like symptoms emerged in IL-6 transgenic mice","volume":"20","author":"Katsume","year":"2002","journal-title":"Cytokine"},{"issue":"22","key":"10.1053\/j.semdp.2016.05.006_bib96","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2011-09-377705","article-title":"HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice","volume":"119","author":"Suthaus","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib97","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":"An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without multicentric Castleman disease","volume":"51","author":"Uldrick","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1053\/j.semdp.2016.05.006_bib98","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib99","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0046-8177(85)80065-4","article-title":"Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases","volume":"16","author":"Weisenburger","year":"1985","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib101","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1309\/AJCPULI3W6WUGGPY","article-title":"Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems","volume":"142","author":"Courville","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.pas.0000172293.59785.b4","article-title":"Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma)","volume":"30","author":"Li","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib104","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10428194.2011.608447","article-title":"Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge","volume":"53","author":"Montes-Moreno","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1053\/j.semdp.2016.05.006_bib105","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder","volume":"100","author":"Du","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12185-011-0975-8","article-title":"A case of successful management of HHV-8(+), EBV(+) germinotropic lymphoproliferative disorder (GLD)","volume":"95","author":"Oh","year":"2012","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib107","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12185-011-0849-0","article-title":"Lymph node-based disease and HHV-8\/KSHV infection in HIV seronegative patients: report of three new cases of a heterogeneous group of diseases","volume":"93","author":"D\u05f3Antonio","year":"2011","journal-title":"Int J Hematol"},{"issue":"7","key":"10.1053\/j.semdp.2016.05.006_bib108","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/10428190701387039","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder: a rare lymphoproliferative disease of HIV patient with plasmablastic morphology, indolent course and favourable response to therapy","volume":"48","author":"D\u05f3Antonio","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1053\/j.semdp.2016.05.006_bib109","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.humpath.2015.06.020","article-title":"Rare variants in the spectrum of human herpesvirus 8\/Epstein-Barr virus-copositive lymphoproliferations","volume":"46","author":"Papoudou-Bai","year":"2015","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V95.1.56","article-title":"Improvement in Castleman\u05f3s disease by humanized anti-interleukin-6 receptor antibody therapy","volume":"95","author":"Nishimoto","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.semdp.2016.05.006_bib111","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2016.05.006_bib112","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman\u05f3s disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"van Rhee","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2016.05.006_bib113","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/1078-0432.CCR-14-1678","article-title":"FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease","volume":"21","author":"Deisseroth","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib114","first-page":"212","article-title":"Chromosomal abnormalities in Castleman\u05f3s disease with high levels of serum interleukin-6","volume":"34","author":"Nakamura","year":"1993","journal-title":"Rinsho Ketsueki"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib115","doi-asserted-by":"crossref","first-page":"e54610","DOI":"10.1371\/journal.pone.0054610","article-title":"Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels","volume":"8","author":"Stone","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1053\/j.semdp.2016.05.006_bib116","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1440-1827.2001.01266.x","article-title":"HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman\u05f3s disease","volume":"51","author":"Suda","year":"2001","journal-title":"Pathol Int"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib117","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1066896908315812","article-title":"Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases","volume":"16","author":"Kojima","year":"2008","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/106689690401200104","article-title":"Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases","volume":"12","author":"Kojima","year":"2004","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3960\/jslrt.53.57","volume":"53","author":"Kawabata","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"10.1053\/j.semdp.2016.05.006_bib120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2431-14-139","article-title":"The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman\u05f3s disease","volume":"14","author":"Kubokawa","year":"2014","journal-title":"BMC Pediatr"},{"issue":"13","key":"10.1053\/j.semdp.2016.05.006_bib121","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2169\/internalmedicine.52.9482","article-title":"Successful treatment of a patient with multicentric Castleman\u05f3s disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody","volume":"52","author":"Kawabata","year":"2013","journal-title":"Intern Med"},{"issue":"4","key":"10.1053\/j.semdp.2016.05.006_bib122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1620\/tjem.236.289","article-title":"Successful treatment of TAFRO syndrome, a variant of multicentric Castleman\u05f3s disease, with Cyclosporine A: possible pathogenetic contribution of interleukin-2","volume":"236","author":"Konishi","year":"2015","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10.1053\/j.semdp.2016.05.006_bib123","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.53.95","article-title":"Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A: a case report","volume":"53","author":"Inoue","year":"2013","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.semdp.2016.05.006_bib125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ajh.23644","article-title":"POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Dispenzieri","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.semdp.2016.05.006_bib126","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib127","first-page":"543","article-title":"Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases","volume":"13","author":"Takatsuki","year":"1983","journal-title":"Jpn J Clin Oncol"},{"issue":"24","key":"10.1053\/j.semdp.2016.05.006_bib128","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2010-11-316935","article-title":"Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients","volume":"117","author":"Dao","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2016.05.006_bib129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bjh.12236","article-title":"New advances in the diagnosis and treatment of POEMS syndrome","volume":"161","author":"Li","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025701630034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025701630034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T21:55:17Z","timestamp":1600552517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074025701630034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":127,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S074025701630034X"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2016.05.006","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicentric Castleman disease: Where are we now?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}